Couverture de eCysticFibrosis Review

eCysticFibrosis Review

eCysticFibrosis Review

De : eCysticFibrosis Review
Écouter gratuitement

À propos de ce contenu audio

 Expert insight and analysis providing information directly relevant to cystic fibrosis care, through topic-focused newsletters summarizing the peer-reviewed literature and accompanying podcasts to illustrate how to apply that information in the clinic.

Hosted on Acast. See acast.com/privacy for more information.

DKBmed 2019 Hygiène et vie saine Maladie et pathologies physiques
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Cystic Fibrosis Life Transitions

      Cystic Fibrosis Life Transitions
      Jul 3 2025
      Until the advent of highly effective CFTR modulator medications, cystic fibrosis was considered a pediatric disease, because most individuals did not survive into adulthood. Now, with more adults living with CF than children, priorities must change. In these interviews, we discuss what transitions to a longer life with CF entails: from pediatric to adult care; from the possibilities of motherhood and the need for family planning; from adulthood into older age and the infirmities common to all aging adults.

      Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      13 min
    • CF and Diet and Nutrition: The Changing Paradigm

      CF and Diet and Nutrition: The Changing Paradigm
      Dec 23 2022

      Individuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how has the current widespread use of highly effective modulator treatments — HEMT — changed that situation? That’s the focus of this eCysticFibrosis Review Special Edition: CF and Nutrition and HEMT. 

      The first part of this program presented an evidence-based Expert Commentary on the current status of weight gain, obesity, and nutrition among people with CF by guest author Katie McDonald, PhD, MS, RDN, CSP, a clinical dietitian at Primary Children's Medical Center in Salt Lake City. The second part is a podcast interview, providing further in-depth discussions between Katie McDonald and three top CF nutrition experts. 


      Take our post-test to claim CME credits.

      Read this podcast's companion newsletter here.

      Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      38 min
    • ETI (CFTR Triple Therapy): Clinical Opportunities

      ETI (CFTR Triple Therapy): Clinical Opportunities
      Sep 14 2022

      The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three agents really better than two? For which patients, in what circumstances? What does the CF Team need to understand to ensure their patients get maximum benefit?

      Join us as we explore these questions with guest author Professor Edward McKone MD, from St. Vincent’s University Hospital and University College Dublin School of Medicine, in this eCysticFibrosis Review podcast.


      Take our post-test to claim CME credits.

      Read this podcast's companion newsletter here.

      Hosted on Acast. See acast.com/privacy for more information.
      Afficher plus Afficher moins
      28 min
    Aucun commentaire pour le moment